Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-15-002335

Options or other derivatives

  • Director acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

HALPRYN GLENN L · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2015-07-06 Grant or award : show line 1 in the form Employee Stock Options (right to buy) +75,000 339,309 D
Loading xslF345X03/form4-07072015_020737.xml…